Federal health officials have worried that reducing nicotine in cigarettes would lead smokers to consume more. A recent study indicates those concerns may be overstated.
Scientists at Wake Forest University School of Medicine analyzed 17 clinical trials with over 5,500 smokers. Those who switched to cigarettes containing about 95% less nicotine did not smoke more to compensate.
Earlier attempts at low-nicotine cigarettes failed
The fear stems from the era of “light” cigarettes. Those products relied on ventilated filters rather than lowering nicotine. Many smokers inhaled more deeply or lit up more often, exposing themselves to the same harmful chemicals. Current low-nicotine cigarettes take a different approach by significantly reducing the addictive compound itself.
Related: Fish oil benefits overstated in new study
Rachel Denlinger-Apte, an assistant professor at Wake Forest and the study’s lead researcher, stated the results challenge long-held assumptions. None of the trials showed an increase in average daily cigarette use among participants assigned to very low nicotine cigarettes. Sixteen of the 17 studies found that smokers cut their intake.
The team also tracked carbon monoxide exposure, which reveals how much smoke a person inhales. There was no sign that participants took deeper drags. After six weeks, fewer than 1% were expected to smoke more than before switching.
New rules could change smoking behavior
The FDA has proposed requiring cigarettes and some other combustible tobacco products to contain only minimally addictive nicotine levels. While the agency’s review continues, this research provides scientific backing for the plan. If enacted, the rule could help current smokers quit and prevent young people from developing addictions.
Related: User reports platform error after account blocked
Cigarette use in the U.S. has reached historic lows, yet 25 million people still smoke. Tobacco remains a leading cause of preventable death. Denlinger-Apte noted the findings could lead to significant public health improvements if the FDA proceeds.
Some trial participants even tried quitting on their own. The study, published in JAMA Network Open, did not follow long-term success rates, but the short-term reduction in smoking appears encouraging.
Should the FDA rule take effect, it would represent one of the boldest tobacco regulations in decades. The agency hasn’t set a final decision timeline, but this evidence may accelerate the process.
